Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
about
The generation and function of soluble apoE receptors in the CNSThe genetic epidemiology of neurodegenerative disease.Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregationMolecular interactions between apoE and ABCA1: impact on apoE lipidationIsoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer diseaseReelin expression and glycosylation patterns are altered in Alzheimer's diseaseApolipoprotein E and Alzheimer diseaseAlzheimer disease: new concepts on its neurobiology and the clinical role imaging will playApolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapyAllosteric modulator Desformylflustrabromine relieves the inhibition of α2β2 and α4β2 nicotinic acetylcholine receptors by β-amyloid(1-42) peptideTranscriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's diseaseReelin signaling antagonizes beta-amyloid at the synapseSimilar promotion of Abeta1-42 fibrillogenesis by native apolipoprotein E epsilon3 and epsilon4 isoformsCardiovascular damage in Alzheimer disease: autopsy findings from the Bryan ADRC.Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta poresAdvances in development of fluorescent probes for detecting amyloid-β aggregatesCerebrovascular disease in ageing and Alzheimer's diseaseApolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer diseaseSuccessful therapies for Alzheimer's disease: why so many in animal models and none in humans?Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactionsDo Microglia Default on Network Maintenance in Alzheimer's Disease?Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learningβ-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's diseaseNeuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer diseaseReelin and apoE actions on signal transduction, synaptic function and memory formationApolipoprotein E and Alzheimer disease: risk, mechanisms and therapyThe role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal modelsApolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-β in human Alzheimer brainApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosisApolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factorsExtensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's diseasePuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer's amyloid-β precursor protein via a tissue-specific proximal regulatory element (PRE)Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome datasetIsoform-specific effects of apoE on neurite outgrowth in olfactory epithelium cultureNeuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer diseaseDiffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxinsBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialPET amyloid-beta imaging in preclinical Alzheimer's diseaseGenomic variants, genes, and pathways of Alzheimer's disease: An overview.Cytoskeletal pathologies of Alzheimer disease
P2860
Q21202840-A4213EF2-5BE2-4343-991B-316FAA2DB68FQ22306301-67E3B37F-E118-447E-9120-69256CB23C06Q24291128-F642D8FF-0031-4C72-B6F0-654A74CEE966Q24306797-222A12AC-C34F-49A3-AE3C-D475E1E90BC5Q24308731-D10F69C7-86DA-4AB7-B54F-2FC11D18BDB2Q24541523-0B166940-7700-4350-B8DA-38EF8650CDC7Q24563061-0DA88461-3434-4D4B-AE0C-D330CDA876BBQ24594531-7937778E-122B-4E05-8426-91D503B873FAQ24604376-36BD8A32-9799-4B30-8815-8AB8018DED26Q24629740-81B232EB-7476-4012-978B-EA0A035AD756Q24631387-21E37AEC-8FDA-4C9F-9515-CBE446DE42C1Q24651028-F5BD0140-9D84-4F2F-BBA2-19C504E86426Q24805441-6F64D465-7F30-46DE-B963-036018A5E192Q24811731-EE67685A-93A3-40BD-B89A-D2BB7B76559CQ26738355-9F420F4E-E1B4-477E-BEA8-3DD050D44DB1Q26753175-39F53026-9B05-499E-BBC6-A6DC0196CAABQ26771852-A4CB3047-E302-41B7-BCE2-C1606E390A31Q26858870-BA2F42D9-03B0-461E-8C15-6FF93D10AA20Q26859305-63604455-3498-421C-A2C8-FDBDE564705FQ26864965-BB45697F-F816-4415-8F6D-95ABE9C94C9CQ28066112-5721E7C8-8CA5-4CEF-B3A1-0760C1A87908Q28217153-8CC70908-C5D1-48C4-9ACC-5CB2A1E870A1Q28245473-942F11E4-C8F1-4D3D-97D6-633FDFA43D47Q28252760-2D50F12D-41C4-4D38-BD9B-08A457349AA4Q28254650-FEF0CC71-474A-4FA3-8587-320E4380A886Q28282855-CDE8DC04-C797-4525-8FCD-EE69139985CDQ28307028-D3D00755-07B5-4D9D-9B21-6DE6AE504F28Q28477020-3A9EB7F8-2CC7-4449-BF40-886313144FA8Q28504715-C5876B96-67A3-4D14-954B-FD53F736117CQ28576453-1805EC3A-B9D1-43BA-B50B-1FAFD5B89B64Q28588684-038E5099-0BA7-4FFA-A8A9-0C2CEB38D7E7Q28706304-FDD2B23C-CCF2-4303-8CAB-764E4C7A0A88Q28730795-4D84D8AC-6591-4B97-BF26-FF3D845D635DQ28771485-6132E359-91C6-4211-93B1-B138E6B976A8Q28775941-2171AB57-E3DA-4E57-BCE7-4DBD08F1A717Q29547593-4CB0FDEA-E1FB-426D-9FF4-673BFE70D014Q29994589-BA8F3FEC-02A2-42C6-8E50-F7BD3E596270Q30040695-1F9EB990-C276-4B6A-AE2A-BF58805186E0Q30240093-F78634A8-35F0-490D-AAEE-66224039D696Q30435267-043603AE-137E-42DA-ADB2-BD6A52261745
P2860
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Increased amyloid beta-peptide ...... n late-onset Alzheimer disease
@ast
Increased amyloid beta-peptide ...... n late-onset Alzheimer disease
@en
type
label
Increased amyloid beta-peptide ...... n late-onset Alzheimer disease
@ast
Increased amyloid beta-peptide ...... n late-onset Alzheimer disease
@en
prefLabel
Increased amyloid beta-peptide ...... n late-onset Alzheimer disease
@ast
Increased amyloid beta-peptide ...... n late-onset Alzheimer disease
@en
P2093
P2860
P356
P1476
Increased amyloid beta-peptide ...... n late-onset Alzheimer disease
@en
P2093
A M Saunders
C M Hulette
D E Schmechel
D Goldgaber
M A Pericak-Vance
W J Strittmatter
P2860
P304
P356
10.1073/PNAS.90.20.9649
P407
P577
1993-10-01T00:00:00Z